Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Attention Deficit Disorder with Hyperactivity | 20 | 2024 | 3658 | 2.360 |
Why?
|
Child Development Disorders, Pervasive | 9 | 2014 | 615 | 2.000 |
Why?
|
Bipolar Disorder | 15 | 2022 | 5027 | 1.260 |
Why?
|
Antimanic Agents | 6 | 2022 | 522 | 0.970 |
Why?
|
Autistic Disorder | 5 | 2021 | 1185 | 0.840 |
Why?
|
Methylphenidate | 3 | 2020 | 473 | 0.750 |
Why?
|
Cerebellar Nuclei | 1 | 2019 | 52 | 0.710 |
Why?
|
Rest | 3 | 2020 | 901 | 0.680 |
Why?
|
Buspirone | 1 | 2018 | 82 | 0.640 |
Why?
|
Comorbidity | 15 | 2024 | 10388 | 0.610 |
Why?
|
Affective Symptoms | 2 | 2018 | 407 | 0.610 |
Why?
|
Cerebellum | 3 | 2020 | 1488 | 0.600 |
Why?
|
Adolescent | 42 | 2024 | 85779 | 0.570 |
Why?
|
Social Behavior Disorders | 1 | 2016 | 97 | 0.540 |
Why?
|
Memantine | 1 | 2016 | 100 | 0.530 |
Why?
|
Neural Pathways | 4 | 2020 | 2974 | 0.520 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 7 | 2014 | 1953 | 0.520 |
Why?
|
Child | 38 | 2024 | 77709 | 0.510 |
Why?
|
Conduct Disorder | 3 | 2022 | 241 | 0.490 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2016 | 449 | 0.460 |
Why?
|
Substance-Related Disorders | 4 | 2021 | 4257 | 0.450 |
Why?
|
Referral and Consultation | 5 | 2018 | 3531 | 0.450 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1433 | 0.430 |
Why?
|
Obsessive-Compulsive Disorder | 3 | 2010 | 1444 | 0.430 |
Why?
|
Psychotropic Drugs | 1 | 2017 | 894 | 0.400 |
Why?
|
Central Nervous System Stimulants | 2 | 2019 | 1148 | 0.400 |
Why?
|
Isoxazoles | 1 | 2013 | 216 | 0.400 |
Why?
|
Dibenzothiazepines | 1 | 2011 | 103 | 0.400 |
Why?
|
Family Health | 2 | 2013 | 1281 | 0.390 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2022 | 6036 | 0.350 |
Why?
|
Gyrus Cinguli | 2 | 2012 | 1091 | 0.340 |
Why?
|
Interview, Psychological | 2 | 2011 | 812 | 0.340 |
Why?
|
Models, Neurological | 1 | 2017 | 1775 | 0.340 |
Why?
|
Young Adult | 17 | 2022 | 56429 | 0.340 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 3 | 2011 | 304 | 0.340 |
Why?
|
Carbamazepine | 1 | 2010 | 229 | 0.340 |
Why?
|
Antipsychotic Agents | 3 | 2022 | 3057 | 0.340 |
Why?
|
Brain Mapping | 3 | 2020 | 6670 | 0.330 |
Why?
|
Cerebral Cortex | 3 | 2020 | 5709 | 0.320 |
Why?
|
Mental Disorders | 4 | 2017 | 6598 | 0.310 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2010 | 503 | 0.300 |
Why?
|
Glutamic Acid | 1 | 2012 | 1169 | 0.290 |
Why?
|
Case-Control Studies | 9 | 2022 | 21748 | 0.270 |
Why?
|
Benzodiazepines | 2 | 2022 | 1101 | 0.270 |
Why?
|
Male | 36 | 2022 | 350115 | 0.250 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15535 | 0.250 |
Why?
|
Anxiety | 1 | 2018 | 4293 | 0.240 |
Why?
|
Humans | 49 | 2024 | 744366 | 0.230 |
Why?
|
Delayed-Action Preparations | 3 | 2019 | 968 | 0.230 |
Why?
|
Adolescent Psychiatry | 1 | 2024 | 148 | 0.210 |
Why?
|
Family | 1 | 2013 | 3147 | 0.210 |
Why?
|
Child Psychiatry | 1 | 2024 | 220 | 0.200 |
Why?
|
Female | 31 | 2022 | 380193 | 0.190 |
Why?
|
Cost of Illness | 1 | 2010 | 1860 | 0.190 |
Why?
|
Guanfacine | 1 | 2020 | 51 | 0.190 |
Why?
|
Pyrimidines | 1 | 2013 | 2943 | 0.190 |
Why?
|
Brief Psychiatric Rating Scale | 2 | 2018 | 108 | 0.190 |
Why?
|
Brain | 3 | 2022 | 26388 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 35425 | 0.170 |
Why?
|
Psychopathology | 1 | 2021 | 409 | 0.160 |
Why?
|
Treatment Outcome | 11 | 2022 | 63107 | 0.160 |
Why?
|
Anxiety Disorders | 4 | 2017 | 2690 | 0.160 |
Why?
|
Adult | 12 | 2022 | 214052 | 0.150 |
Why?
|
Wechsler Scales | 1 | 2017 | 260 | 0.150 |
Why?
|
Prospective Studies | 11 | 2022 | 53290 | 0.150 |
Why?
|
Psychopharmacology | 1 | 2018 | 143 | 0.140 |
Why?
|
Ambulatory Care | 2 | 2018 | 2708 | 0.130 |
Why?
|
Age of Onset | 2 | 2014 | 3270 | 0.130 |
Why?
|
Pilot Projects | 4 | 2022 | 8319 | 0.120 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1344 | 0.110 |
Why?
|
Diffusion Tensor Imaging | 1 | 2022 | 2305 | 0.110 |
Why?
|
Psychiatry | 1 | 2024 | 1695 | 0.100 |
Why?
|
Child, Preschool | 5 | 2022 | 41005 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8949 | 0.090 |
Why?
|
Massachusetts | 3 | 2013 | 8662 | 0.090 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2012 | 312 | 0.090 |
Why?
|
Obsessive Behavior | 1 | 2010 | 47 | 0.090 |
Why?
|
Double-Blind Method | 2 | 2022 | 12025 | 0.090 |
Why?
|
Compulsive Behavior | 1 | 2010 | 117 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10943 | 0.080 |
Why?
|
Propylamines | 1 | 2009 | 165 | 0.080 |
Why?
|
Automobile Driving | 1 | 2013 | 431 | 0.080 |
Why?
|
Personality Assessment | 1 | 2010 | 647 | 0.080 |
Why?
|
Triazines | 1 | 2010 | 315 | 0.080 |
Why?
|
Social Behavior | 1 | 2014 | 1127 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2022 | 39052 | 0.080 |
Why?
|
Phobic Disorders | 1 | 2010 | 439 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2010 | 4933 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 9955 | 0.070 |
Why?
|
Checklist | 2 | 2013 | 833 | 0.070 |
Why?
|
Child Behavior Disorders | 1 | 2012 | 807 | 0.070 |
Why?
|
Research Design | 1 | 2022 | 5984 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12244 | 0.070 |
Why?
|
Oxygen | 1 | 2017 | 4189 | 0.070 |
Why?
|
Panic Disorder | 1 | 2009 | 616 | 0.070 |
Why?
|
Psychometrics | 2 | 2011 | 3003 | 0.060 |
Why?
|
Exanthema | 1 | 2010 | 501 | 0.060 |
Why?
|
Psychotherapy | 1 | 2014 | 1642 | 0.060 |
Why?
|
Depression | 2 | 2017 | 7759 | 0.060 |
Why?
|
Piperazines | 2 | 2022 | 2488 | 0.060 |
Why?
|
Quinolones | 1 | 2007 | 367 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2013 | 4266 | 0.060 |
Why?
|
Tic Disorders | 1 | 2024 | 127 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13991 | 0.060 |
Why?
|
Attention | 1 | 2013 | 2397 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3759 | 0.050 |
Why?
|
Outpatients | 1 | 2010 | 1487 | 0.050 |
Why?
|
Psychology | 1 | 2024 | 356 | 0.050 |
Why?
|
Inositol | 1 | 2022 | 218 | 0.050 |
Why?
|
Educational Status | 2 | 2022 | 2540 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2022 | 271 | 0.050 |
Why?
|
Alcoholism | 1 | 2011 | 1906 | 0.050 |
Why?
|
Quality of Life | 1 | 2021 | 12802 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2010 | 1916 | 0.050 |
Why?
|
Infant | 1 | 2021 | 35134 | 0.040 |
Why?
|
Risperidone | 1 | 2022 | 383 | 0.040 |
Why?
|
Time Factors | 2 | 2019 | 40075 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2018 | 77460 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4671 | 0.040 |
Why?
|
Risk Factors | 5 | 2018 | 72296 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 40559 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 12961 | 0.040 |
Why?
|
Boston | 1 | 2010 | 9312 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14723 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2011 | 19905 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2013 | 4639 | 0.030 |
Why?
|
Pediatrics | 1 | 2010 | 3475 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1483 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 8987 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2013 | 6366 | 0.030 |
Why?
|
Prevalence | 1 | 2009 | 15221 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2016 | 6994 | 0.030 |
Why?
|
Middle Aged | 2 | 2016 | 213390 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2838 | 0.020 |
Why?
|
Asperger Syndrome | 1 | 2010 | 63 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2016 | 977 | 0.020 |
Why?
|
Sex Factors | 2 | 2013 | 10400 | 0.020 |
Why?
|
Parents | 1 | 2021 | 3405 | 0.020 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2009 | 189 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2009 | 426 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2010 | 1681 | 0.020 |
Why?
|
Child of Impaired Parents | 1 | 2011 | 455 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7914 | 0.020 |
Why?
|
Drug Tolerance | 1 | 2007 | 376 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18373 | 0.020 |
Why?
|
Mood Disorders | 1 | 2010 | 1106 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2760 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
Computer Simulation | 1 | 2013 | 6194 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7785 | 0.010 |
Why?
|
Patient Selection | 1 | 2009 | 4216 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3395 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12356 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16367 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25039 | 0.010 |
Why?
|
United States | 1 | 2011 | 69872 | 0.000 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_